Logo image of LIN.DE

LINDE PLC (LIN.DE) Stock Fundamental Analysis

FRA:LIN - Deutsche Boerse Ag - IE000S9YS762 - Common Stock - Currency: EUR

403.8  -4.2 (-1.03%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to LIN. LIN was compared to 69 industry peers in the Chemicals industry. While LIN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. LIN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

LIN had positive earnings in the past year.
In the past year LIN had a positive cash flow from operations.
LIN had positive earnings in each of the past 5 years.
In the past 5 years LIN always reported a positive cash flow from operatings.
LIN.DE Yearly Net Income VS EBIT VS OCF VS FCFLIN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

1.2 Ratios

With an excellent Return On Assets value of 7.99%, LIN belongs to the best of the industry, outperforming 85.51% of the companies in the same industry.
With an excellent Return On Equity value of 17.38%, LIN belongs to the best of the industry, outperforming 91.30% of the companies in the same industry.
The Return On Invested Capital of LIN (9.45%) is better than 79.71% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LIN is in line with the industry average of 6.66%.
The last Return On Invested Capital (9.45%) for LIN is above the 3 year average (8.64%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.99%
ROE 17.38%
ROIC 9.45%
ROA(3y)7.02%
ROA(5y)5.72%
ROE(3y)14.4%
ROE(5y)11.44%
ROIC(3y)8.64%
ROIC(5y)7.15%
LIN.DE Yearly ROA, ROE, ROICLIN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

LIN has a better Profit Margin (20.02%) than 98.55% of its industry peers.
In the last couple of years the Profit Margin of LIN has grown nicely.
Looking at the Operating Margin, with a value of 27.03%, LIN belongs to the top of the industry, outperforming 98.55% of the companies in the same industry.
In the last couple of years the Operating Margin of LIN has grown nicely.
With a decent Gross Margin value of 48.26%, LIN is doing good in the industry, outperforming 71.01% of the companies in the same industry.
LIN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 27.03%
PM (TTM) 20.02%
GM 48.26%
OM growth 3Y15.4%
OM growth 5Y17.98%
PM growth 3Y16.98%
PM growth 5Y19.7%
GM growth 3Y3.75%
GM growth 5Y3.21%
LIN.DE Yearly Profit, Operating, Gross MarginsLIN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), LIN is creating some value.
Compared to 1 year ago, LIN has less shares outstanding
LIN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for LIN is higher compared to a year ago.
LIN.DE Yearly Shares OutstandingLIN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
LIN.DE Yearly Total Debt VS Total AssetsLIN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

An Altman-Z score of 3.93 indicates that LIN is not in any danger for bankruptcy at the moment.
LIN has a better Altman-Z score (3.93) than 76.81% of its industry peers.
The Debt to FCF ratio of LIN is 4.87, which is a neutral value as it means it would take LIN, 4.87 years of fcf income to pay off all of its debts.
LIN has a Debt to FCF ratio of 4.87. This is in the better half of the industry: LIN outperforms 73.91% of its industry peers.
A Debt/Equity ratio of 0.58 indicates that LIN is somewhat dependend on debt financing.
LIN has a worse Debt to Equity ratio (0.58) than 60.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 4.87
Altman-Z 3.93
ROIC/WACC1.11
WACC8.48%
LIN.DE Yearly LT Debt VS Equity VS FCFLIN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

LIN has a Current Ratio of 0.94. This is a bad value and indicates that LIN is not financially healthy enough and could expect problems in meeting its short term obligations.
LIN has a Current ratio of 0.94. This is amonst the worse of the industry: LIN underperforms 85.51% of its industry peers.
A Quick Ratio of 0.80 indicates that LIN may have some problems paying its short term obligations.
LIN has a worse Quick ratio (0.80) than 76.81% of its industry peers.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.8
LIN.DE Yearly Current Assets VS Current LiabilitesLIN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.05% over the past year.
Measured over the past years, LIN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.11% on average per year.
LIN shows a small growth in Revenue. In the last year, the Revenue has grown by 0.78%.
LIN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.18% yearly.
EPS 1Y (TTM)8.05%
EPS 3Y13.21%
EPS 5Y16.11%
EPS Q2Q%5.33%
Revenue 1Y (TTM)0.78%
Revenue growth 3Y2.34%
Revenue growth 5Y3.18%
Sales Q2Q%0.15%

3.2 Future

Based on estimates for the next years, LIN will show a small growth in Earnings Per Share. The EPS will grow by 7.63% on average per year.
LIN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.78% yearly.
EPS Next Y6.85%
EPS Next 2Y8.2%
EPS Next 3Y9.89%
EPS Next 5Y7.63%
Revenue Next Year1.16%
Revenue Next 2Y3.39%
Revenue Next 3Y4.1%
Revenue Next 5Y4.78%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LIN.DE Yearly Revenue VS EstimatesLIN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B
LIN.DE Yearly EPS VS EstimatesLIN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15 20

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 29.76, the valuation of LIN can be described as expensive.
LIN's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of LIN to the average of the S&P500 Index (26.57), we can say LIN is valued inline with the index average.
A Price/Forward Earnings ratio of 25.74 indicates a quite expensive valuation of LIN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LIN is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of LIN to the average of the S&P500 Index (22.41), we can say LIN is valued inline with the index average.
Industry RankSector Rank
PE 29.76
Fwd PE 25.74
LIN.DE Price Earnings VS Forward Price EarningsLIN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LIN is valued a bit more expensive than the industry average as 63.77% of the companies are valued more cheaply.
LIN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 44.8
EV/EBITDA 18.49
LIN.DE Per share dataLIN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of LIN may justify a higher PE ratio.
PEG (NY)4.35
PEG (5Y)1.85
EPS Next 2Y8.2%
EPS Next 3Y9.89%

3

5. Dividend

5.1 Amount

LIN has a Yearly Dividend Yield of 1.28%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.00, LIN has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, LIN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.28%

5.2 History

On average, the dividend of LIN grows each year by 9.70%, which is quite nice.
Dividend Growth(5Y)9.7%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

40.75% of the earnings are spent on dividend by LIN. This is a bit on the high side, but may be sustainable.
The dividend of LIN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP40.75%
EPS Next 2Y8.2%
EPS Next 3Y9.89%
LIN.DE Yearly Income VS Free CF VS DividendLIN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
LIN.DE Dividend Payout.LIN.DE Dividend Payout, showing the Payout Ratio.LIN.DE Dividend Payout.PayoutRetained Earnings

LINDE PLC

FRA:LIN (6/16/2025, 7:00:00 PM)

403.8

-4.2 (-1.03%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners87.42%
Inst Owner ChangeN/A
Ins Owners0.21%
Ins Owner ChangeN/A
Market Cap190.08B
Analysts76.25
Price Target442.91 (9.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.28%
Yearly Dividend4.83
Dividend Growth(5Y)9.7%
DP40.75%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.13%
Min EPS beat(2)-0.37%
Max EPS beat(2)0.12%
EPS beat(4)3
Avg EPS beat(4)0.18%
Min EPS beat(4)-0.37%
Max EPS beat(4)0.75%
EPS beat(8)7
Avg EPS beat(8)0.74%
EPS beat(12)11
Avg EPS beat(12)2.47%
EPS beat(16)15
Avg EPS beat(16)2.74%
Revenue beat(2)0
Avg Revenue beat(2)-2.45%
Min Revenue beat(2)-2.54%
Max Revenue beat(2)-2.37%
Revenue beat(4)0
Avg Revenue beat(4)-1.84%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)-0.88%
Revenue beat(8)1
Avg Revenue beat(8)-2.81%
Revenue beat(12)3
Avg Revenue beat(12)-2.13%
Revenue beat(16)7
Avg Revenue beat(16)-1.05%
PT rev (1m)-1.42%
PT rev (3m)-8.87%
EPS NQ rev (1m)0.05%
EPS NQ rev (3m)-1.77%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.5%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)-0.57%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)-0.59%
Valuation
Industry RankSector Rank
PE 29.76
Fwd PE 25.74
P/S 6.66
P/FCF 44.8
P/OCF 22.84
P/B 5.78
P/tB N/A
EV/EBITDA 18.49
EPS(TTM)13.57
EY3.36%
EPS(NY)15.69
Fwd EY3.89%
FCF(TTM)9.01
FCFY2.23%
OCF(TTM)17.68
OCFY4.38%
SpS60.6
BVpS69.81
TBVpS-0.07
PEG (NY)4.35
PEG (5Y)1.85
Profitability
Industry RankSector Rank
ROA 7.99%
ROE 17.38%
ROCE 13.08%
ROIC 9.45%
ROICexc 10.19%
ROICexgc 23.42%
OM 27.03%
PM (TTM) 20.02%
GM 48.26%
FCFM 14.87%
ROA(3y)7.02%
ROA(5y)5.72%
ROE(3y)14.4%
ROE(5y)11.44%
ROIC(3y)8.64%
ROIC(5y)7.15%
ROICexc(3y)9.31%
ROICexc(5y)7.64%
ROICexgc(3y)23.08%
ROICexgc(5y)19.1%
ROCE(3y)11.99%
ROCE(5y)9.81%
ROICexcg growth 3Y14.81%
ROICexcg growth 5Y23.95%
ROICexc growth 3Y18.89%
ROICexc growth 5Y24.77%
OM growth 3Y15.4%
OM growth 5Y17.98%
PM growth 3Y16.98%
PM growth 5Y19.7%
GM growth 3Y3.75%
GM growth 5Y3.21%
F-Score7
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 4.87
Debt/EBITDA 1.74
Cap/Depr 126.14%
Cap/Sales 14.29%
Interest Coverage 250
Cash Conversion 76.04%
Profit Quality 74.29%
Current Ratio 0.94
Quick Ratio 0.8
Altman-Z 3.93
F-Score7
WACC8.48%
ROIC/WACC1.11
Cap/Depr(3y)97.89%
Cap/Depr(5y)86.75%
Cap/Sales(3y)11.55%
Cap/Sales(5y)11.43%
Profit Quality(3y)100.43%
Profit Quality(5y)127.18%
High Growth Momentum
Growth
EPS 1Y (TTM)8.05%
EPS 3Y13.21%
EPS 5Y16.11%
EPS Q2Q%5.33%
EPS Next Y6.85%
EPS Next 2Y8.2%
EPS Next 3Y9.89%
EPS Next 5Y7.63%
Revenue 1Y (TTM)0.78%
Revenue growth 3Y2.34%
Revenue growth 5Y3.18%
Sales Q2Q%0.15%
Revenue Next Year1.16%
Revenue Next 2Y3.39%
Revenue Next 3Y4.1%
Revenue Next 5Y4.78%
EBIT growth 1Y8.72%
EBIT growth 3Y18.1%
EBIT growth 5Y21.73%
EBIT Next Year39.36%
EBIT Next 3Y16.68%
EBIT Next 5Y12.13%
FCF growth 1Y-9.37%
FCF growth 3Y-9.47%
FCF growth 5Y14.47%
OCF growth 1Y9.78%
OCF growth 3Y-1.05%
OCF growth 5Y8.77%